Lelis, Felipe
Byk, Laura A.
Pustylnikov, Sergei
Nguyen, Vivian
Nguyen, Brandon
Nitz, Malorie
Tarte, Prutha
Tungare, Kunal
Li, Jilong
Manna, Saikat
Maiti, Sampa
Mehta, Dhwani H.
Sekar, Narendran
Posadas, Diana M.
Dhamankar, Himanshu
Hughes, Jeffrey A.
Aulisa, Lorenzo
Khan, Amin
Melo, Mariane B.
Dey, Antu K.
Article History
Received: 24 May 2023
Accepted: 30 October 2023
First Online: 1 December 2023
Competing interests
: F.L., L.A.B., S.P., V.N., B.N., M.N., P.T., J.L., D.H.M., N.S., D.M.P., H.D., A.K., M.B.M. and A.K.D. are employees of GreenLight Biosciences Inc. K.T., Saikat Manna, Sampa Maiti, J.A.H. and L.A. are former employees of GreenLight Biosciences Inc. All authors declare no non-financial competing interests. GreenLight Biosciences’ mRNA vaccines are the subject of GreenLight Biosciences’ pending patent applications U.S. App. No. 17/734,703 and WIPO App. No. PCT/US2022/027290.